Aug 7, 2019

Hospitals' drug bills are likely going up in 2020

Go deeper

How Democrats want to limit drug prices

Illustration: Rebecca Zisser/Axios

The Democratic presidential candidates' plans to lower drug prices are much more aggressive than what the party has supported in the past.

Between the lines: There are big differences among the candidates' platforms, but the entire debate has shifted to the left.

Go deeperArrowAug 8, 2019

The fight over the future of our most expensive drugs

Illustration: Sarah Grillo/Axios

The market designed to create competition for biologics — typically our most expensive drugs — has been slow to take off, but some experts say that even its best-case scenario doesn't do enough to lower drug prices.

Why it matters: While wonks debate the future of biosimilars in policy journals and on editorial pages, the argument is reflected in the political divide over whether enhanced drug competition or price regulation is the best way to address drug prices.

Go deeperArrowAug 26, 2019

The U.S. doesn't spend less on social care than other developed countries

A new Health Affairs study throws cold water on the idea that the U.S. spends so much more on health care than other countries because we spend less on other social services.

The big picture: Some policymakers and researchers say that the underinvestment in social services has led to a less healthy population, and point to the low U.S. ratio of social-to-health spending.

Go deeperArrowAug 15, 2019